Navigation Links
PDI and The Medical Affairs Company Enter Exclusive Strategic Alliance
Date:6/3/2009

SADDLE RIVER, N.J. and KENNESAW, Ga., June 3 /PRNewswire-FirstCall/ -- Two leaders in the pharmaceutical contract services industry, PDI, Inc. (Nasdaq: PDII), a provider of sales and marketing support to U.S. pharmaceutical companies, and The Medical Affairs Company (TMAC(R)), the leading provider of customized Medical Science Liaison (MSL) and Medical Affairs services, have signed an agreement aligning their respective services in order to bring clients a more complete set of field-based commercialization solutions.

Under the exclusive agreement, PDI and TMAC will integrate their service offerings to benefit client brands, participate in joint client presentations and exchange new business leads. By operating under this agreement, both PDI and TMAC are better able to meet a wider variety of client demands for best-in-class field resources, while preserving the important separation of pharmaceutical sales and medical departments.

"The MSL plays an increasingly crucial role in pharmaceuticals today - that of providing high-level scientific information to key opinion leaders and other medical doctors on a peer-to-peer basis," said Nancy Lurker, Chief Executive Officer, PDI. "We're very pleased to partner with TMAC through this strategic alliance. TMAC's expertise in providing MSL services to pharmaceutical companies is highly regarded. Our agreement increases PDI's ability to provide maximum value to our clients and fills a critical need for a higher science personal engagement with physicians."

TMAC Chief Executive Officer Evan Demestihas, M.D., believes the agreement will give each company even greater leverage to build their business in a highly competitive industry. "With our partnership, we each gain a more complete suite of field services, and that places us in an even better position to seize growth opportunities. I am delighted that TMAC will be working alongside PDI, a nationally recognized, leading Contract Services Organization."

About PDI

PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility, sales, marketing and commercialization expertise.

PDI currently operates in three business segments: Sales Services, Marketing Services and Product Commercialization. Our sales services include Performance Sales Teams(TM), which are dedicated pharmaceutical sales force teams for specific customers; Select Access(TM), our targeted sales solution that leverages an existing sales force and infrastructure; and PDI ON DEMAND, a suite of innovative services that provide rapid, customized sales force solutions tailored to meet the local, regional and seasonal needs of our customers. Our marketing services include marketing research services through TVG Marketing Research & Consulting and medical communications services through Pharmakon. Our product commercialization solutions leverage our considerable sales and marketing expertise to manage products throughout their lifecycles. PDI's experience extends across multiple therapeutic categories and includes office- and hospital-based initiatives.

For more information, please visit the Company's website at www.pdi-inc.com.

About The Medical Affairs Company

The Medical Affairs Company LLC (TMAC(R)) is a full service Contract Medical Organization that provides pharmaceutical, biotechnology, and medical device industry clients a wide array of outsourcing capabilities for medical affairs activities. Offering both strategic and tactical medical liaison support services in addition to medical liaison consulting and medical communications support, TMAC is uniquely positioned to provide both unmatched value and service to the pharmaceutical industry. TMAC's greatest strength is their focus: medical and scientific affairs - it is their only business.

For more information, please visit the Company's website at www.themedicalaffairscompany.com.

TMAC(R) is a registered trademark of The Medical Affairs Company LLC


'/>"/>
SOURCE PDI, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Regado Biosciences Establishes Medical Advisory Board
2. Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service
3. For Medical Device Makers, a New Software Technology Report, Time to Get Rid of Your Old Code from Full Spectrum Software
4. Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market
5. The Foundation for Biomedical Research Wins Telly Award for Majestic
6. SPO Medical Expands Professional Product Offering
7. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
8. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
9. China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug
10. The Hamner Institutes Announce Partnership With China Medical City
11. China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 AskLinkerReports.com has published a report ... Amyloglucosidase Industry 2016 Market Research Report. From a basic outline ... overview are all covered in the report. This report projects ... analysis of the Amyloglucosidase industry. ... , , ...
(Date:12/8/2016)... ... December 08, 2016 , ... Opal Kelly, a ... device-to-computer interconnect using USB or PCI Express, announced the FOMD-ACV-A4, the company's first ... a small, thin, SODIMM-style module that fits a standard 204-pin SODIMM socket for ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... announces the commercial launch of flexible packaging for their exceptionally efficient human ... bag system extends RoosterBio’s portfolio of bioprocess media products engineered to radically ...
(Date:12/8/2016)... 8, 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), ... and plans to commercialize innovative therapeutics for patients ... stock were approved for trading on the OTCQX ... the OTCQX, effective today, under the ticker symbol ... market, companies must meet high financial standards, follow ...
Breaking Biology Technology:
(Date:12/6/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, and the ... five (5) year funding commitment by Securus to ... rehabilitation and reentry support to more inmates and ... 2004, the Prison Entrepreneurship Program (PEP) is an ...
(Date:11/30/2016)... -- higi SH llc (higi) announced today the launch ... industry thought-leaders and celebrity influencers looking to encourage, ... steps to live healthier, more active lives. ... built the largest self-screening health station network in ... have conducted over 185 million biometric screenings.  The ...
(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
Breaking Biology News(10 mins):